Nearly one-third of adult employees would change jobs in order to gain coverage. As the demand for GLP-1 weight loss ...
Medici writes a recent survey from hiring platform Checkr found 58% of Americans looking for jobs said securing an interview ...
Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.
The costs of blockbuster weight-loss drugs, projected to double again this year, will likely boost premiums for Blue Cross ...
Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...
Jab for joy? A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting ...
When the FDA declared an Ozempic and Wegovy shortage, business boomed for pharmacies making cheaper, off-brand versions of ...